Digestive Health

News Watch

In this interview, filmed during the 4th Gut Microbiota for Health World Summit, Professor Magnus Simrén of the University of Gothenburg (Sweden) and Chairman of the United European Gastroenterology (UEG) Scientific Committee, explains to Gut Microbiota Worldwatch the relationship between the gut microbiota and irritable bowel syndrome (IBS). The video tells us exactly what irritable bowel syndrome is, what kind of…

GMFH Editing Team
GMFH Editing Team

In this interview, filmed during the 4th Gut Microbiota for Health World Summit, Professor Magnus Simrén of the University of Gothenburg (Sweden) and Chairman of the United European Gastroenterology (UEG) Scientific Committee, explains to Gut Microbiota Worldwatch the relationship between the gut microbiota and irritable bowel syndrome (IBS). The video tells us exactly what irritable bowel syndrome is, what kind of…

GMFH Editing Team
GMFH Editing Team

Abdominal pain, bloating, changes in stool frequency and consistency. These are just some of the symptoms associated with Irritable Bowel Syndrome (IBS), a chronic functional disorder whose origins are unknown. It has no known treatment, only recommendations to keep symptoms at bay. In Western countries, almost two out of ten gastroenterology consultations are motivated by this disorder.   Professor Magnus Simrén, researcher at…

GMFH Editing Team
GMFH Editing Team

Abdominal pain, bloating, changes in stool frequency and consistency. These are just some of the symptoms associated with Irritable Bowel Syndrome (IBS), a chronic functional disorder whose origins are unknown. It has no known treatment, only recommendations to keep symptoms at bay. In Western countries, almost two out of ten gastroenterology consultations are motivated by this disorder.   Professor Magnus Simrén, researcher at…

GMFH Editing Team
GMFH Editing Team

Colorectal cancer (also known as bowel cancer) is the third most common cancer in the world, according to World Cancer Research Fund International. By 2035, it is predicted there will be 2.4 million cases of this type of tumour diagnosed annually worldwide, mostly in developed countries. The risk of developing it is about 1 in 20 (5%) and it is…

GMFH Editing Team
GMFH Editing Team

Colorectal cancer (also known as bowel cancer) is the third most common cancer in the world, according to World Cancer Research Fund International. By 2035, it is predicted there will be 2.4 million cases of this type of tumour diagnosed annually worldwide, mostly in developed countries. The risk of developing it is about 1 in 20 (5%) and it is…

GMFH Editing Team
GMFH Editing Team

As we have explained before in this blog, breast milk is one major way in which an infant’s gut microbiota starts developing. We now know that an antibody contained in breast milk provides lifelong protection from illnesses such as the inflammatory bowel disease (IBD), by setting up defences in the gut flora of breastfed babies. These are the main findings…

GMFH Editing Team
GMFH Editing Team

As we have explained before in this blog, breast milk is one major way in which an infant’s gut microbiota starts developing. We now know that an antibody contained in breast milk provides lifelong protection from illnesses such as the inflammatory bowel disease (IBD), by setting up defences in the gut flora of breastfed babies. These are the main findings…

GMFH Editing Team
GMFH Editing Team

Transferring microbes from the colon of a mouse with a colorectal tumour to a healthy mouse means the latter will also develop cancer, according to a study recently published in mBio® by Zackular JP  et al., the open access journal of The American Academy of Microbiology. It was already known that inflammation played an important role in the development of colorectal…

GMFH Editing Team
GMFH Editing Team

Transferring microbes from the colon of a mouse with a colorectal tumour to a healthy mouse means the latter will also develop cancer, according to a study recently published in mBio® by Zackular JP  et al., the open access journal of The American Academy of Microbiology. It was already known that inflammation played an important role in the development of colorectal…

GMFH Editing Team
GMFH Editing Team

Research & Practice

Lactose intolerance is a form of lactose maldigestion where individuals experience symptoms such as diarrhoea, abdominal cramping, flatulence, vomiting, and bowel sounds following lactose consumption. An estimated 30% of the population from the United States and Mediterranean countries may suffer from this condition, although lactose intolerance prevalence is lower in northern European countries and higher in African and Asian countries.…

Paul Enck
Prof. Dr. Paul Enck, Director of Research, Dept. of Psychosomatic Medicine and Psychotherapy, University Hospital Tübingen, Germany. His main interests are gut functions in health and disease, including functional and inflammatory bowel disorders, the role of the gut microbiota, regulation of eating and food intake and its disorders, of nausea, vomiting and motion sickness, and the psychophysiology and neurobiology of the placebo response, with specific emphasis on age and gender contributions. He has published more than 170 original data paper in scientific, peer-reviewed journals, and more than 250 book chapters and review articles. He is board member/treasurer of the European Society of Neurogastroenterology and Motility and of the German Society of Neurogastroenterology and Motility, and has served as reviewer for many international journals and grant agencies.

Lactose intolerance is a form of lactose maldigestion where individuals experience symptoms such as diarrhoea, abdominal cramping, flatulence, vomiting, and bowel sounds following lactose consumption. An estimated 30% of the population from the United States and Mediterranean countries may suffer from this condition, although lactose intolerance prevalence is lower in northern European countries and higher in African and Asian countries.…

Paul Enck
Prof. Dr. Paul Enck, Director of Research, Dept. of Psychosomatic Medicine and Psychotherapy, University Hospital Tübingen, Germany. His main interests are gut functions in health and disease, including functional and inflammatory bowel disorders, the role of the gut microbiota, regulation of eating and food intake and its disorders, of nausea, vomiting and motion sickness, and the psychophysiology and neurobiology of the placebo response, with specific emphasis on age and gender contributions. He has published more than 170 original data paper in scientific, peer-reviewed journals, and more than 250 book chapters and review articles. He is board member/treasurer of the European Society of Neurogastroenterology and Motility and of the German Society of Neurogastroenterology and Motility, and has served as reviewer for many international journals and grant agencies.

Celiac disease is an autoimmune condition involving an immune reaction that is triggered by dietary gluten, found in wheat, barley and rye. Partially digested gluten peptides can trigger symptoms in genetically susceptible individuals, expressing HLA-DQ2 or DQ8 genes. While necessary for disease development, the expression of DQ2/DQ8 is not sufficient for disease development, suggesting a critical role for environmental factors.…

Heather Galipeau
Heather Galipeau is a Research Associate at McMaster University (Canada) where she is researching dietary and microbial interactions in celiac disease and inflammatory bowel disease. She obtained her PhD in 2015 from McMaster University in Elena Verdu’s lab, during which she found that the small intestinal microbial background influences the degree of immuno-pathology triggered by dietary antigens, such as gluten.

Celiac disease is an autoimmune condition involving an immune reaction that is triggered by dietary gluten, found in wheat, barley and rye. Partially digested gluten peptides can trigger symptoms in genetically susceptible individuals, expressing HLA-DQ2 or DQ8 genes. While necessary for disease development, the expression of DQ2/DQ8 is not sufficient for disease development, suggesting a critical role for environmental factors.…

Heather Galipeau
Heather Galipeau is a Research Associate at McMaster University (Canada) where she is researching dietary and microbial interactions in celiac disease and inflammatory bowel disease. She obtained her PhD in 2015 from McMaster University in Elena Verdu’s lab, during which she found that the small intestinal microbial background influences the degree of immuno-pathology triggered by dietary antigens, such as gluten.

Small intestinal bacterial overgrowth (SIBO) refers to a condition in which abnormally large numbers of bacteria are present in the small intestine. Gastrointestinal cancer is related to compromised intestinal barrier function, reduced functionality of immune responses, and inadequate nutritional status, which impair the ability of patients to control intestinal bacterial proliferation. These result in conditions favourable to SIBO. However, the…

Paul Enck
Prof. Dr. Paul Enck, Director of Research, Dept. of Psychosomatic Medicine and Psychotherapy, University Hospital Tübingen, Germany. His main interests are gut functions in health and disease, including functional and inflammatory bowel disorders, the role of the gut microbiota, regulation of eating and food intake and its disorders, of nausea, vomiting and motion sickness, and the psychophysiology and neurobiology of the placebo response, with specific emphasis on age and gender contributions. He has published more than 170 original data paper in scientific, peer-reviewed journals, and more than 250 book chapters and review articles. He is board member/treasurer of the European Society of Neurogastroenterology and Motility and of the German Society of Neurogastroenterology and Motility, and has served as reviewer for many international journals and grant agencies.

Small intestinal bacterial overgrowth (SIBO) refers to a condition in which abnormally large numbers of bacteria are present in the small intestine. Gastrointestinal cancer is related to compromised intestinal barrier function, reduced functionality of immune responses, and inadequate nutritional status, which impair the ability of patients to control intestinal bacterial proliferation. These result in conditions favourable to SIBO. However, the…

Paul Enck
Prof. Dr. Paul Enck, Director of Research, Dept. of Psychosomatic Medicine and Psychotherapy, University Hospital Tübingen, Germany. His main interests are gut functions in health and disease, including functional and inflammatory bowel disorders, the role of the gut microbiota, regulation of eating and food intake and its disorders, of nausea, vomiting and motion sickness, and the psychophysiology and neurobiology of the placebo response, with specific emphasis on age and gender contributions. He has published more than 170 original data paper in scientific, peer-reviewed journals, and more than 250 book chapters and review articles. He is board member/treasurer of the European Society of Neurogastroenterology and Motility and of the German Society of Neurogastroenterology and Motility, and has served as reviewer for many international journals and grant agencies.

The incidence of food allergies has increased dramatically in western countries over the past 20 years and the gut microbiota seems to be a promising target for preventing and treating them. However, mechanisms by which gut microbiota is involved in the loss of oral tolerance remain unclear.   A recent study, led by Dr. Charles Mackay from the Monash Biomedicine…

Andreu Prados
Andreu Prados holds a Bachelor of Science Degree in Pharmacy & Human Nutrition and Dietetics. Science writer specialised in gut microbiota and probiotics, working also as lecturer and consultant in nutrition and healthcare. Follow Andreu on Twitter @andreuprados

The incidence of food allergies has increased dramatically in western countries over the past 20 years and the gut microbiota seems to be a promising target for preventing and treating them. However, mechanisms by which gut microbiota is involved in the loss of oral tolerance remain unclear.   A recent study, led by Dr. Charles Mackay from the Monash Biomedicine…

Andreu Prados
Andreu Prados holds a Bachelor of Science Degree in Pharmacy & Human Nutrition and Dietetics. Science writer specialised in gut microbiota and probiotics, working also as lecturer and consultant in nutrition and healthcare. Follow Andreu on Twitter @andreuprados

A diet low in FODMAPs (fermentable oligosaccharides, disaccharides, monosaccharides and polyols) has been studied mostly in the context of irritable bowel syndrome (IBS) and is known to reduce functional gastrointestinal symptoms in this population. In addition, altering FODMAP intake appears to impact fecal microbiota composition in both healthy individuals and those with IBS. The observed success of the low-FODMAP diet…

Kristina Campbell
Science writer Kristina Campbell (M.Sc.), from British Columbia (Canada), specializes in communicating about the gut microbiota, digestive health, and nutrition. Author of the best selling Well-Fed Microbiome Cookbook, her freelance work has appeared in publications around the world. Kristina joined the Gut Microbiota for Health publishing team in 2014.  Find her on: GoogleTwitter

A diet low in FODMAPs (fermentable oligosaccharides, disaccharides, monosaccharides and polyols) has been studied mostly in the context of irritable bowel syndrome (IBS) and is known to reduce functional gastrointestinal symptoms in this population. In addition, altering FODMAP intake appears to impact fecal microbiota composition in both healthy individuals and those with IBS. The observed success of the low-FODMAP diet…

Kristina Campbell
Science writer Kristina Campbell (M.Sc.), from British Columbia (Canada), specializes in communicating about the gut microbiota, digestive health, and nutrition. Author of the best selling Well-Fed Microbiome Cookbook, her freelance work has appeared in publications around the world. Kristina joined the Gut Microbiota for Health publishing team in 2014.  Find her on: GoogleTwitter